The company has allotted 3,11,111 equity shares of Rs. 10/- each at an issue price of Rs. 45/- (premium of Rs. 35/- on each equity share) on conversion of warrants issued on preferential basis.
Vivo Bio Tech Ltd. Press Release Apr 08 2025
Filed with BSE ·
6ix hasn’t read this filing yet.
Earlier from Vivo Bio Tech
- Vivo Bio Tech Ltd. Press Release Mar 29 2025
- Announcement under Regulation 30 (LODR)-Allotment
- Vivo Bio Tech Ltd. Press Release Mar 27 2025
- Closure of Trading Window
- Vivo Bio Tech Ltd. Press Release Mar 08 2025
Later from Vivo Bio Tech
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
- Vivo Bio Tech Ltd. Press Release Apr 11 2025
- Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
- Vivo Bio Tech Ltd. Press Release Apr 21 2025
- Announcement under Regulation 30 (LODR)-Resignation of Director
Follow Vivo Bio Tech into a list and get an email when it puts out news.
Follow Vivo Bio Tech